Drugdiscovery >> Drugs >> News
3804
Views
Noxafil is recommended by the EU Committee - drugdiscovery.com
Noxafil is recommended by the EU Committee - drugdiscovery.com


Merck announced that th Committee for Medicinal Products for Human Use of the European Medicines Agency has expressed a positive opinion and recommended Noxafil. The drug is in a new, investigational tablet form.
Read More >>


Tags: drug, Noxafil, Merck, tablet, EU. - March 2, 2014
Related Articles
6058
Views
 Pfizer’s perosnalized medicine drug for lung cancer not recommended by NICE Pfizer’s perosnalized medicine drug for lung cancer not recommended by NICE
Xalkori (crizotinib) should be used as a later line treatment of ALK positive, advanced non small cell lung cancer (NSCLC) patients. NICE has acknowledged that the drug may offer better outcomes comp Read More >>

Tags: Xalkori, crizotinib, advanced, non small cell lung cancer, NICE

3290
Views
EMA Committee gives positive opinion to NovoEight EMA Committee gives positive opinion to NovoEight
The EMA Committee recommended marketing authorization for Novo Nordisk’s NovoEight, a recombinant coagulation factor VIII, indicated for the treatment and prophylaxis of bleeding in patients with he Read More >>

Tags: NovoEight, Novo Nordisk, EMA, recombinant coagulation factor VIII, hemophilia A, treatment, prophylaxis

4600
Views
EMA Committee gives positive opinion on flu vaccine spray for children EMA Committee gives positive opinion on flu vaccine spray for children
The EMA Committee gave positive opinion on AstraZeneca’ Fluenz Tetra, a nasally administered four-strain live attenuated influenza vaccine, for the prevention of seasonal influenza in eligible child Read More >>

Tags: Astra Zeneca, EU, positive opinion, Fluenz Tetra, flu vaccine

3498
Views
EU Committee recommends the approval of type 2 diabetes drug EU Committee recommends the approval of type 2 diabetes drug
Janssen’s drug, Invokana (canagliflozin), an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors is to be used to impro Read More >>

Tags: Invokana, canagliflozin, Janssen, diabetes, type 2, drug

3869
Views
Positive CHMP opinion for Kineret Positive CHMP opinion for Kineret
Sobi, Kineret, cryopyrin-associated periodic syndromes, CAPS, EMA, EU Read More >>

Tags: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion for the use of Sobi’s drug Kineret for the treatment of patients with cryopyrin-associated periodic syndromes (CAPS).

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013